BACKGROUND: Congenital cytomegalovirus (CMV) infection is the major infectious cause of birth defects and hearing loss globally. There is a growing recognition of the potential clinical impact of congenital CMV infections in high-seroprevalence settings. METHODS: A cross-sectional study of neonatal admissions at a large referral center in sub-Saharan Africa to determine the prevalence of both symptomatic and asymptomatic congenital CMV infection was performed. Real-time polymerase chain reaction was used to screen DNA-extracted sera, urine, and saliva, and an enzyme-linked immunosorbent assay was used to screen serum samples for anti-CMV immunoglobulin M. Multivariate binary logistic regression was used to identify risk factors associated with increased odds of congenital CMV infection. RESULTS: Congenital CMV was detected in 3.8% (15/395) of neonates. Among these infants, 6 of 15 (40%) presented with jaundice, 1 of whom also had petechiae. Congenital CMV infection was detected in 9 of 79 (11.4%; 95% confidence interval [CI], 6.1%-20.3%) neonates born to human immunodeficiency virus (HIV)-infected mothers, and both maternal HIV (odds ratio [OR], 6.661 [95% CI, 2.126-20.876], P = .001) and jaundice (OR, 5.701 [95% CI, 1.776-18.306], P = .003) were independently linked with significantly increased odds of congenital CMV infection. CONCLUSIONS: Congenital and early infant CMV infections may have important consequences for child health in sub-Saharan Africa and other high HIV and CMV seroprevalence populations globally.
BACKGROUND:Congenital cytomegalovirus (CMV) infection is the major infectious cause of birth defects and hearing loss globally. There is a growing recognition of the potential clinical impact of congenital CMV infections in high-seroprevalence settings. METHODS: A cross-sectional study of neonatal admissions at a large referral center in sub-Saharan Africa to determine the prevalence of both symptomatic and asymptomatic congenital CMV infection was performed. Real-time polymerase chain reaction was used to screen DNA-extracted sera, urine, and saliva, and an enzyme-linked immunosorbent assay was used to screen serum samples for anti-CMV immunoglobulin M. Multivariate binary logistic regression was used to identify risk factors associated with increased odds of congenital CMV infection. RESULTS: Congenital CMV was detected in 3.8% (15/395) of neonates. Among these infants, 6 of 15 (40%) presented with jaundice, 1 of whom also had petechiae. Congenital CMV infection was detected in 9 of 79 (11.4%; 95% confidence interval [CI], 6.1%-20.3%) neonates born to human immunodeficiency virus (HIV)-infected mothers, and both maternal HIV (odds ratio [OR], 6.661 [95% CI, 2.126-20.876], P = .001) and jaundice (OR, 5.701 [95% CI, 1.776-18.306], P = .003) were independently linked with significantly increased odds of congenital CMV infection. CONCLUSIONS: Congenital and early infant CMV infections may have important consequences for child health in sub-Saharan Africa and other high HIV and CMV seroprevalence populations globally.
Authors: Adriana Weinberg; Marisa M Mussi-Pinhata; Qilu Yu; Rachel A Cohen; Volia C Almeida; Fabiana R Amaral; Laura Freimanis; Donald Robert Harris; Christiana Smith; George Siberry Journal: AIDS Res Hum Retroviruses Date: 2018-04-23 Impact factor: 2.205
Authors: Kristy M Bialas; Daniel Westreich; Eduardo Cisneros de la Rosa; Cody S Nelson; Lawrence M Kauvar; Tong-Ming Fu; Sallie R Permar Journal: J Infect Dis Date: 2016-10-20 Impact factor: 5.226
Authors: Athena P Kourtis; Jeffrey Wiener; Tiffany S Chang; Sheila C Dollard; Minal M Amin; Sascha Ellington; Dumbani Kayira; Charles van der Horst; Denise J Jamieson Journal: Clin Vaccine Immunol Date: 2015-09-30
Authors: Tiffany S Chang; Jeffrey Wiener; Sheila C Dollard; Minal M Amin; Sascha Ellington; Charles Chasela; Dumbani Kayira; Gerald Tegha; Deborah Kamwendo; Denise J Jamieson; Charlie van der Horst; Athena P Kourtis Journal: AIDS Date: 2015-04-24 Impact factor: 4.177
Authors: Nancy A Otieno; Bryan O Nyawanda; Fredrick Otiato; Martina Oneko; Minal M Amin; Michael Otieno; Daniel Omollo; Meredith McMorrow; Sandra S Chaves; Sheila C Dollard; Tatiana M Lanzieri Journal: J Clin Virol Date: 2019-09-17 Impact factor: 3.168
Authors: Erica L Johnson; Chanie L Howard; Joy Thurman; Kyle Pontiff; Elan S Johnson; Rana Chakraborty Journal: J Infect Dis Date: 2014-07-31 Impact factor: 5.226